Abstract: Development in Machine Learning algorithms has led to early detection and prediction of fatal diseases. Certain websites help patients to identify such diseases. Many pharmaceutical companies use advanced data mining techniques to extract the data from pathological reports of patients to generate statistical reports and decide their drug supply and marketing strategies. Our software bridges the needs of patients as well as pharmaceutical companies by predicting fatal diseases like brain tumour, diabetes mellitus, lung cancer and cardiovascular (heart) diseases for the patient and generating analytical reports from patient’s data which provide a bird’s eye view of prevalence of a disease within an area for the pharma sector.
Keywords: Machine Learning, Diabetes Mellitus, Lung Cancer, Cardiovascular Disease, Brain Tumour
|
DOI:
10.17148/IJARCCE.2022.11231
